SCYNEXIS
SCYX
$1.54
Share price
4.76%
Change (1 day)
-51.11%
Change (1 year)
Categories
SCYNEXIS (SCYX) - Net assets
Net assets on the balance sheet as of September 2023 : $91.99 M
According to SCYNEXIS's latest financial reports the company has $91.99 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
SCYNEXIS - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $3.23 M | -92.16% |
| 2021-12-31 | $41.25 M | 81.29% |
| 2020-12-31 | $22.75 M | 76.49% |
| 2019-12-31 | $12.89 M | -58.7% |
| 2018-12-31 | $31.22 M | 45.84% |
| 2017-12-31 | $21.41 M | -38.51% |
| 2016-12-31 | $34.81 M | -17% |
| 2015-12-31 | $41.94 M | 25.48% |
| 2014-12-31 | $33.43 M | -259.56% |
| 2013-12-31 | $-20.96 M | 8.4% |
| 2012-12-31 | $-19.33 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | $15.54 M | -83.10% | 🇮🇱 Israel |
 Catalyst Pharmaceuticals CPRX | $0.38 B | 321.65% | 🇺🇸 USA |
 Catalent CTLT | $3.68 B | 3,908.00% | 🇺🇸 USA |
 KemPharm KMPH | $85.8 M | -6.72% | 🇺🇸 USA |